Tag Archive for: medical science liaisons

Without question, there has been significant progress in pinpointing treatments and accelerating rare disease diagnosis, largely due to the precision of data-driven commercial strategies and the speed of digital clinical trials.

Changes are ahead for professionals in life sciences sales and marketing, and medical affairs. From the widening gap between AI-users and those companies still holding out; to the next evolution in AI, and how companies will seek to make it more practical on a global scale; to the impact of AI on leveraging digital opinion leaders to get more clinical evidence in the hands of doctors, Aktana offers its predictions for the coming year.

Medical science liaisons (MSLs) play an essential and prominent role in the pharmaceutical industry. To support the various market changes, the scope of the average MSL function will expand. This article explores the evolving role of MSLs and their value for biopharmaceutical companies, and examines how best to utilize their expertise.